Bristol-Myers Squibb Reports First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Bristol-Myers Squibb Co. (BMY) PT Raised to $53 at Deutsche Bank
April 27, 2018 9:19 AM EDTDeutsche Bank raised its price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $53.00 (from $52.00) while maintaining a Hold rating.
... MoreBristol-Myers Squibb (BMY) Tops Q1 EPS by 9c; Raises Outlook
April 26, 2018 7:01 AM EDTBristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $0.94, $0.09 better than the analyst estimate of $0.85. Revenue for the quarter came in at $5.2 billion versus the consensus estimate of $5.24 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2018 EPS of $3.35-$3.45, versus the consensus of... More